Effect of Weight Reduction on Liver Histology and Biochemistry in Patients with Chronic Hepatitis C

Overview

Journal Gut

Specialty Gastroenterology

Date 2002 Jun 22

PMID 12077098

Citations 52

Authors

I J Hickman

A D Clouston

G A Macdonald

D M Purdie

J B Prins

S Ash

J R Jonsson

E E Powell

Affiliations

Soon will be listed here.

Abstract

Background: Steatosis occurs in more than 50% of patients with chronic hepatitis C and is associated with increased hepatic fibrosis. In many of these patients the pathogenesis of steatosis appears to be the same as for patients with non-alcoholic fatty liver disease-that is, related to visceral adiposity and obesity.

Methods: The effect of a three month weight reduction programme on liver biochemistry and metabolic parameters was examined in 19 subjects with steatosis and chronic hepatitis C. Paired liver biopsies were performed in 10 subjects, prior to and 3-6 months following the intervention, to determine the effect of weight loss on liver histology.

Results: There was a mean weight loss of 5.9 (3.2) kg and a mean reduction in waist circumference of 9.0 (5.0) cm. In 16 of the 19 patients, serum alanine aminotransferase levels fell progressively with weight loss. Mean fasting insulin fell from 16 (7) to 11 (4) mmol/l (p<0.002). Nine of 10 patients with paired liver biopsies had a reduction in steatosis irrespective of viral genotype. In these subjects the median modified Knodell fibrosis score decreased from 3 to 1 (p=0.04) and activated stellate cells significantly decreased (p<0.004).

Conclusions: Weight loss in patients with chronic hepatitis C may be associated with a reduction in steatosis and abnormal liver enzymes and an improvement in fibrosis, despite the persistence of the virus. Weight reduction may provide an important adjunct treatment strategy for patients with chronic hepatitis C.

Citing Articles

Association of MASLD Phenotypes With Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk Factors.

Elgretli W, Shengir M, Sasson S, Ramanakumar A, Cinque F, Ballestreros L J Viral Hepat. 2025; 32(2):e70004.

PMID: 39868661 PMC: 11771651. DOI: 10.1111/jvh.70004.

Intermittent fasting and the liver: Focus on the Ramadan model.

Emara M, Soliman H, Said E, Elbatae H, Elazab M, Elhefnawy S World J Hepatol. 2024; 16(8):1070-1083.

PMID: 39221099 PMC: 11362902. DOI: 10.4254/wjh.v16.i8.1070.

Evaluation of treatment access and scope of a multistate hepatitis C virus Extension for Community Healthcare Outcomes telehealth service in the US Indian Health System, 2017-2021.

Wirth A, Cushman N, Reilley B, Leston J, Mera J, Levander X J Rural Health. 2022; 39(2):358-366.

PMID: 36526593 PMC: 10038839. DOI: 10.1111/jrh.12733.

Diagnostic and prognostic significance of hepatic steatosis in patients with chronic hepatitis C.

Stan I, Biciusca V, Durand P, Petrescu A, Oancea D, Ciuciulete A Rom J Morphol Embryol. 2022; 62(3):765-775.

PMID: 35263405 PMC: 9019612. DOI: 10.47162/RJME.62.3.14.

Hepatitis C virus: A critical approach to who really needs treatment.

Kouroumalis E, Voumvouraki A World J Hepatol. 2022; 14(1):1-44.

PMID: 35126838 PMC: 8790391. DOI: 10.4254/wjh.v14.i1.1.

References

Shimomura I, Bashmakov Y, Ikemoto S, Horton J, Brown M, Goldstein J . Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci U S A. 1999; 96(24):13656-61. PMC: 24120. DOI: 10.1073/pnas.96.24.13656. View

Jolly C, Fernandes G . Diet modulates Th-1 and Th-2 cytokine production in the peripheral blood of lupus-prone mice. J Clin Immunol. 1999; 19(3):172-8. DOI: 10.1023/a:1020503727157. View

Adinolfi L, Utili R, Ruggiero G . Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients. Hepatology. 1999; 30(6):1530-1. DOI: 10.1002/hep.510300625. View

Luyckx F, Lefebvre P, Scheen A . Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab. 2000; 26(2):98-106. View

Rubbia-Brandt L, Quadri R, Abid K, Giostra E, Male P, Mentha G . Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol. 2000; 33(1):106-15. DOI: 10.1016/s0168-8278(00)80166-x. View

Booth M, Hunter C, Gore C, Bauman A, Owen N . The relationship between body mass index and waist circumference: implications for estimates of the population prevalence of overweight. Int J Obes Relat Metab Disord. 2000; 24(8):1058-61. DOI: 10.1038/sj.ijo.0801359. View

Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning B, Miroux B . Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet. 2000; 26(4):435-9. DOI: 10.1038/82565. View

Issa R, Williams E, Trim N, Kendall T, Arthur M, Reichen J . Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut. 2001; 48(4):548-57. PMC: 1728234. DOI: 10.1136/gut.48.4.548. View

Clouston A, Jonsson J, Purdie D, Macdonald G, Pandeya N, Shorthouse C . Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation. J Hepatol. 2001; 34(2):314-20. DOI: 10.1016/s0168-8278(00)00096-9. View

10.

Adinolfi L, Gambardella M, Andreana A, Tripodi M, Utili R, Ruggiero G . Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology. 2001; 33(6):1358-64. DOI: 10.1053/jhep.2001.24432. View

11.

Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. DOI: 10.1007/BF00280883. View

12.

Palmer M, Schaffner F . Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology. 1990; 99(5):1408-13. DOI: 10.1016/0016-5085(90)91169-7. View

13.

Safer D . Diet, behavior modification, and exercise: a review of obesity treatments from a long-term perspective. South Med J. 1991; 84(12):1470-4. View

14.

Lean M, Han T, Morrison C . Waist circumference as a measure for indicating need for weight management. BMJ. 1995; 311(6998):158-61. PMC: 2550221. DOI: 10.1136/bmj.311.6998.158. View

15.

ISHAK K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F . Histological grading and staging of chronic hepatitis. J Hepatol. 1995; 22(6):696-9. DOI: 10.1016/0168-8278(95)80226-6. View

16.

Mihm S, Fayyazi A, Hartmann H, Ramadori G . Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology. 1997; 25(3):735-9. DOI: 10.1002/hep.510250340. View

17.

Ramm G, Crawford D, Powell L, Walker N, Fletcher L, Halliday J . Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol. 1997; 26(3):584-92. DOI: 10.1016/s0168-8278(97)80424-2. View

18.

Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y . Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol. 1997; 78 ( Pt 7):1527-31. DOI: 10.1099/0022-1317-78-7-1527. View

19.

Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S . Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol. 1997; 27(1):103-7. DOI: 10.1016/s0168-8278(97)80287-5. View

20.

Dong W, Selgrade M, Gilmour I, Lange R, Park P, Luster M . Altered alveolar macrophage function in calorie-restricted rats. Am J Respir Cell Mol Biol. 1998; 19(3):462-9. DOI: 10.1165/ajrcmb.19.3.3114. View